Page 25 - Randomized Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gap Between Oxford COVID Doses can be Increased to 3 Months by Angela Mohan on  February 22, 2021 at 12:07 PM The Lancet study. According to the findings from a phase 3 randomized controlled trial, the first dose offered 76 per cent protection in the three months between doses. The interval between doses can be safely extended to three months given the protection a single dose offers, which may allow countries to vaccinate a larger proportion of the population more rapidly, the researchers said. "Where there is a limited supply, policies of initially vaccinating more peopl...

Conference Spotlights New Research to Benefit Primary Care Conference Spotlights New Research to Benefit Primary Care  Febuary 4, 2021, 3:24 pm News Staff — The talents of family medicine researchers from across the United States and elsewhere were on full display at the 48th annual meeting of the North American Primary Care Research Group, held virtually late last year. The meeting of more than 850 researchers gave attendees the opportunity to participate in more than 700 forums, oral presentations, poster presentations and workshops. Sessions were offered on demand or via livestream a...

  relapsed or refractory chronic lymphocytic leukaemia   progression after 12 months vs. 68% for comparators   AstraZeneca's Calquence (acalabrutinib), a next-generation, selective Bruton's tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukaemia (CLL) (including small lymphocytic lymphoma [SLL]).   The approval by the Japanese Ministry of Health, Labour and Welfare was based on positive results from the ASCEND Phase III trial and a Phase I tr...

Grand Rounds is a monthly blog series developed by EMS World and FlightBridgeED that will feature top EMS medical directors exploring the intricacies of critical care in EMS practice. In this installment FlightBridgeED Chief Medical Officer Jeffrey Jarvis, MD, PM, reviews the drug ketorolac. Unless you’ve been very committed to keeping your head in the sand, you’ve probably noticed we’re in the midst of an opioid epidemic. Though there is little evidence that the one or two doses of IV opioid medications EMS might give for acute pain contribute to opioid misuse, there are other reasons...

When you’re living with osteoarthritis (OA) pain that can’t be managed with conventional treatments alone, you may consider complementary therapies, too. “Traditional medicine is important,” says Deborah Ballard, M.D., a physician at Duke Integrative Medicine in Durham, NC. But it’s only one tool in the toolbox. Your best bet is to visit an integrative clinic, where you can get a customized healing plan, Dr. Ballard suggests. And whatever you decide to try—even if it’s an OTC supplement—always (always!) talk to your primary care physician first. Here’s what is and isn’t wo...